Mitotic indices, anti‐PCNA immunostaining, and AgNORs in thick cutaneous melanomas displaying paradoxical behaviour
- 1 September 1992
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 168 (1) , 15-22
- https://doi.org/10.1002/path.1711680104
Abstract
Those melanomas which fail to behave as expected from their Breslow thickness provide interesting material for study. In an attempt to explain differences in behaviour, we have evaluated three distinct proliferative markers in 23 thick melanomas which failed to metastasize and in 20 well‐matched control tumours with documented metastasis. The test group demonstrated significantly greater numbers of mitoses when expressed as an index (mitoses per 1000 cells), whilst no difference was found when the results were expressed in terms of mitoses per unit area. Tumours showing epidermal ulceration possessed higher mitotic indices than those of non‐ulcerated lesions. High fractions of PCNA immunolabelling combined with low mitotic indices were observed frequently in the non‐metastasizing group. This result and its possible relation to survival advantage are discussed in detail. Both AgNOR numbers and patterns failed to act as prognostic variables—indeed, AgNORs failed to correiate with the other proliferative indices, suggesting that their value as a marker of tumour growth is severely limited.Keywords
This publication has 33 references indexed in Scilit:
- A critical evaluation of AgNOR counting in benign naevi and malignant melanomaThe Journal of Pathology, 1991
- Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some, neoplasmsThe Journal of Pathology, 1990
- Improved silver staining of nucleolar organiser regions in paraffin wax sections using an inverted incubation technique.Journal of Clinical Pathology, 1990
- Model Predicting Survival in Stage I Melanoma Based on Tumor ProgressionJNCI Journal of the National Cancer Institute, 1989
- Proliferative Activity of Cutaneous Melanocytic Tumors Defined by Ki-67 Monoclonal AntibodyThe American Journal of Dermatopathology, 1989
- DNA content and MHC class II antigen expression in malignant melanoma: clinical course.Journal of Clinical Pathology, 1988
- Lethal “Thin” Malignant MelanomaAnnals of Surgery, 1988
- DNA ploidy in thin melanomaPathology, 1988
- Ulceration and prognosis in cutaneous malignant melanomaHistopathology, 1982
- Thickness, Cross-Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous MelanomaAnnals of Surgery, 1970